维生素D水平对放射学轴性脊柱关节炎两年疾病活动、功能与健康的影响:GESPIC队列数据
该研究基于GESPIC队列,纳入122例开始bDMARD治疗的活动性r-axSpA患者,基线时53.3%存在维生素D缺乏(<20 ng/mL)。纵向分析显示,正常维生素D水平与较低的ASDAS、BASDAI、PGA和BASFI相关,但效应量较小,敏感性分析后部分关联减弱但方向一致。结论认为正常维生素D水平与较低的疾病活动度适度相关,监测和优化维生素D状态可能有助于疾病控制。
要点
- 基线53.3%的r-axSpA患者存在维生素D缺乏(<20 ng/mL)。
- 正常维生素D水平与较低的ASDAS、BASDAI、PGA和BASFI相关,但效应量较小。
- 敏感性分析后ASDAS、BASDAI、BASFI、CRP的效应估计减弱但方向一致。
核心结论
- 正常维生素D水平与接受bDMARD治疗的r-axSpA患者较低的疾病活动度适度相关。
- 监测和优化维生素D状态可能有助于更好的疾病控制。
研究设计与样本
- 基于GErman SPondyloarthritis Inception Cohort (GESPIC)的分析,纳入122例基线活动性r-axSpA且开始bDMARD治疗的患者。
- 基线及每6个月至第2年测量25-羟基维生素D,缺乏定义为<20 ng/mL。
- 采用广义估计方程评估纵向关联,并进行敏感性分析以考虑时间变化的混杂因素。
主要发现
- 患者平均年龄36.6(10.3)岁,66.4%为男性,53.3%基线存在维生素D缺乏。
- 正常维生素D水平与较低的ASDAS相关(β每增加1 ng/mL:-0.010;95% CI -0.017至-0.003)。
- 正常维生素D水平与较低的BASDAI相关(β:-0.021;95% CI -0.036至-0.006)。
- 正常维生素D水平与较低的PGA相关(β:-0.021;95% CI -0.039至-0.003)。
- 正常维生素D水平与BASFI相关(β:-0.015;95% CI -0.032至0.001)。
关键数值与推荐
- 维生素D缺乏定义为25-羟基维生素D <20 ng/mL。
- 结局包括ASDAS、BASDAI、PGA、BASFI、ASAS-HI和CRP。
临床怎么用
- 在r-axSpA患者接受bDMARD治疗时,可监测维生素D水平并优化其状态以支持疾病控制。
局限性
- ASDAS、BASDAI、BASFI、CRP及其分类结局的效应估计在敏感性分析中减弱。
- PGA和ASAS-HI的正向关联在所有模型中不一致。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To investigate the impact of vitamin D on disease activity, function and health in patients with radiographic axial spondyloarthritis (r-axSpA) undergoing biological disease-modifying antirheumatic drug (bDMARD) therapy. METHODS: Patients with r-axSpA and active disease at baseline initiating a bDMARD were included in this analysis. Vitamin D (25-hydroxyvitamin D) was measured at baseline and every 6 months until year 2; deficiency was defined as <20 ng/mL. The outcomes were AxSpA Disease Activity Score (ASDAS), Bath Ankylosing Spondylitis Disease Activity Index (BASDAI), Patient Global Assessment (PGA), Bath Ankylosing Spondylitis Functional Index (BASFI), Assessment of SpondyloArthritis international Society Health Index (ASAS-HI) and C reactive protein (CRP). Longitudinal associations were evaluated using generalised estimating equations, with sensitivity analyses accounting for time-varying confounders. RESULTS: We analysed 122 patients (mean age 36.6 (10.3) years; 66.4% male), of whom 53.3% had vitamin D deficiency at baseline. In longitudinal models, normal vitamin D levels were associated with lower ASDAS (β per 1 ng/mL increase: -0.010; 95% CI -0.017 to -0.003), BASDAI (β: -0.021; 95% CI -0.036 to -0.006), PGA (β: -0.021; 95% CI -0.039 to -0.003) and BASFI (β: -0.015; 95% CI -0.032 to 0.001). Effect estimates of ASDAS, BASDAI, BASFI, CRP (and their corresponding categorical outcomes) were attenuated in sensitivity analyses but remained directionally consistent. Positive associations with PGA and ASAS-HI were also observed though the estimates were not consistent through all models. CONCLUSIONS: Normal vitamin D levels were modestly associated with lower disease activity in r-axSpA treated with bDMARDs. Monitoring and optimising vitamin D status may support better disease control.
引用
- Torgutalp M, Proft F, Haibel H, et al. Impact of vitamin D levels on disease activity, function and health over 2 years in radiographic axial spondyloarthritis: data from GErman SPondyloarthritis Inception Cohort (GESPIC). RMD Open. 2026. PMID: 42457207. doi:10.1136/rmdopen-2026-006921
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。